SCHEMBL24370132

SCHEMBL24370132

C=CCCOC(=O)c1cccc(C(F)(F)F)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.53
LMNA P02545 2/20 0.50
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
ALDH1A1 P00352 4/20 0.47
HPGD P15428 2/20 0.47
HTT P42858 1/20 0.47
NPSR1 Q6W5P4 2/20 0.47
CYP1A2 P05177 3/20 0.47
CYP3A4 P08684 3/20 0.47
CYP2C19 P33261 2/20 0.47
GAA P10253 2/20 0.47
USP2 O75604 2/20 0.46
NPC1 O15118 1/20 0.46
HSP90AA1 P07900 1/20 0.46
XBP1 P17861 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
SRD5A2 P31213 1/20 0.46
NR1I2 O75469 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14780442 0.85 CES2 (0.56) CES2LMNAMEN1KMT2AALDH1A1
SCHEMBL2834471 0.82 CES2 (0.47) CES2MEN1KMT2AALDH1A1NPC1
SCHEMBL20267329 0.81 LMNA (0.60) CES2LMNAALDH1A1HPGDNPSR1
SCHEMBL31575815 0.81 LMNA (0.60) CES2LMNAALDH1A1HPGDNPSR1
SCHEMBL7409219 0.81 CES2 (0.57) CES2LMNAALDH1A1HPGDNPSR1
SCHEMBL849861 0.80 RHOC (0.37) CES2ALDH1A1PRKCAPRKCDMAOB
SCHEMBL16024757 0.79 NPSR1 (0.56) CES2LMNAALDH1A1HPGDHTT
SCHEMBL28051732 0.79 L3MBTL1 (0.52) KMT2AHPGDNPSR1CYP2C19NPC1
SCHEMBL715874 0.79 CES2 (0.59) CES2LMNAMEN1KMT2AALDH1A1
SCHEMBL18669871 0.78 CES2 (0.54) CES2LMNAALDH1A1HPGDNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127228-A1 METHOD FOR PRODUCING DICHLORO ADDITION PRODUCT OF ALIPHATIC OLEFIN BY PHOTOCATALYSIS UNDER VISIBLE LIGHT SOOCHOW UNIVERSITY (CN) 2022-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127228-A1 METHOD FOR PRODUCING DICHLORO ADDITION PRODUCT OF ALIPHATIC OLEFIN BY PHOTOCATALYSIS UNDER VISIBLE LIGHT AOC1, AOC2, AOC3 CES2 671/4885LMNA 3716/4885MEN1 2300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.